RWD149 Real-World Comparison of Cardiovascular Benefits between Sodium-Glucose Cotransporter 2 (SGLT-2I) and Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Inhibitors in Patients with Type 2 Diabetes (T2D)

D Huang, B Greenwood + Show 3 more

https://doi.org/10.1016/j.jval.2023.03.2178

Copy DOI

Publication Date: Jun 1, 2023

Abstract

This study examined cardiovascular benefits among patients with T2D newly initiated on SGLT-2i or GLP-1RA using real-world claims data.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author